CN108452370A - A kind of compound supramolecular hydrogel and preparation method thereof - Google Patents

A kind of compound supramolecular hydrogel and preparation method thereof Download PDF

Info

Publication number
CN108452370A
CN108452370A CN201810421517.6A CN201810421517A CN108452370A CN 108452370 A CN108452370 A CN 108452370A CN 201810421517 A CN201810421517 A CN 201810421517A CN 108452370 A CN108452370 A CN 108452370A
Authority
CN
China
Prior art keywords
solution
cordycepin
chitosan
compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810421517.6A
Other languages
Chinese (zh)
Other versions
CN108452370B (en
Inventor
张翼
宋茹茹
王杨
郑俊
刘依林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central South University
Original Assignee
Central South University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central South University filed Critical Central South University
Priority to CN201810421517.6A priority Critical patent/CN108452370B/en
Publication of CN108452370A publication Critical patent/CN108452370A/en
Application granted granted Critical
Publication of CN108452370B publication Critical patent/CN108452370B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of compound supramolecular hydrogels and preparation method thereof, belong to supramolecular hydrogel technical field.Using chitosan as gelator, using " freeze-thaw method ", the compound supramolecular hydrogel of milky is formd with traditional Chinese medicine monomer cordycepin in PBS buffer solutions.The hydrogel component is the good natural products of biocompatibility, and the synergistic effect of chitosan and cordycepin enhances the anti-microbial property of the present invention.The present invention has self-healing, the performances such as smearable, two components of the compound supramolecular hydrogel not only increase the anti-microbial property of composite material by synergistic effect, and can reduce skin wound scar and be formed, and have broad application prospects in the fields such as anti-biotic material and wound dressing.

Description

A kind of compound supramolecular hydrogel and preparation method thereof
Technical field
The present invention relates to a kind of compound supramolecular hydrogels and preparation method thereof, belong to supramolecular hydrogel technology neck Domain.
Background technology
Up to the present, various wound-healing materials have been commercialized;However, clinical practice shows the need for still having new It asks, because they are intended only as the temporary barrier for preventing infection and body fluid to be lost in.Wound healing deficiency is easy to form chronic wounds Or lead to the complication of threat to life.Wound healing is a complexity and dynamic process, is divided into the predictable stage:Blood is solidifying (Gu hemostasis), inflammation, tissue growth (proliferation) and tissue remodeling (maturation).In each stage, the system secreted by inflammatory cell Row cell factor and growth factor play an important roll for restoring impaired eucaryotic cell structure and organized layer.In this respect, people It has been primarily focused on skin graft using growth factor functionalization and/or based on cell.It is cured being related to wound In the cell of conjunction process, macrophage may infect, tissue repair and solution inflammation.As host defense person, macrophage Identification and adventive is destroyed, remove dead and impaired structural constituent (classics activation), and generated and adjust tissue growth and again The cell factor of modeling, growth factor and angiogenesis factor activation).Therefore, exploitation has biocompatibility good, without side-effects Hydrogel wound dressing be that this field is in demand.
Hydrogel (Hydrogel) is the gel using water as decentralized medium.There is good biocompatibility to be dropped with biology for it Solution ability is frequently utilized for the holder of organizational project, wound repair, the fields such as drug conveying.More and more researchers are closed at present Note its application as wound dressing.Hydrogel has as wound dressing to be absorbed Wound exudate, sterilization, moisturizing, promotes wound The effect of the healing of mouth.The supramolecular hydrogel composite material with ideal antibiotic property and biocompatibility is designed for exploitation Novel wound dressing has a very important significance.
Invention content
In order to solve the above technical problems, the present invention provides a kind of compound supramolecular hydrogels with good antibiotic property And preparation method thereof, which has self-healing, smearable performance, is applied in anti-biotic material and wound There is good application prospect in terms of material.
In order to achieve the above objectives, technical scheme is as follows:A kind of compound supramolecular hydrogel, including cordycepin Solution, chitosan solution and PBS buffer solutions.
As a preferred embodiment of the present invention, a concentration of 100mg/mL of the cordycepin solution.
As a preferred embodiment of the present invention, the solvent of the chitosan solution is 1%HAc, the chitosan solution A concentration of 20~40mg/L.
As a preferred embodiment of the present invention, the solvent of the PBS buffer solutions is ultra-pure water, and the PBS bufferings are molten The PH of liquid is 8.3~8.5, each phosphate concn used is 0.1mol/L.
As a preferred embodiment of the present invention, the compound supramolecular hydrogel is applied to antiseptic or/and wound In dressing.
A kind of preparation method of compound supramolecular hydrogel, includes the following steps:
Step 1, the preparation of cordycepin solution;With dmso solution cordycepin solid powder, ultrasonic disperse obtains worm Careless element solution;
Step 2, the preparation of chitosan solution;Chitosan is dissolved with 1%HAc, magnetic agitation is matched to accelerate chitosan to dissolve At chitosan solution;
Step 3, the preparation of PBS buffer solutions;Use Na2HPO4And NaH2PO4Solution allocation is molten at the PBS bufferings of different Ph Liquid;
Step 4, after mixing by the cordycepin solution, chitosan solution and PBS buffer solutions, it is put into -20 DEG C of ice Case is refrigerated to after fully charge to place to thaw at room temperature, forms the compound supramolecular hydrogel.
As the prioritization scheme to above-mentioned preparation method, in step 1, the dmso solution cordycepin solid powder Time by ultrasonic disperse is 5~10min, and gained cordycepin solution concentration is 100mg/mL, and preparing, the cordycepin is molten It carries out being protected from light processing during liquid.
As the prioritization scheme to above-mentioned preparation method, in step 2, a concentration of 20~40mg/ of the chitosan solution ml;In step 3, the Ph of the PBS buffer solutions is 8.3~8.5, and in the PBS buffer solutions, Na2HPO4 and NaH2PO4 are dense Degree is 0.1mol/L.
As the prioritization scheme to above-mentioned preparation method, step 4, the cordycepin solution of 80 μ of μ L~100 L is taken to be added It is protected from light in the screw socket bottle of processing to the 2.0mL for cleaning drying, rapidly joins the PBS buffer solutions of 400~420 μ L, rapidly It shakes up, adds the chitosan solution of 500 μ L, be made into the mixed solution of 1.0mL, the process for preparation of the mixed solution exists It is carried out under magnetic agitation;The mixed solution is waited for after mixing, after screw socket bottle is put into -20 DEG C of refrigerator freezings to fully charge Placement is thawed at room temperature, forms the compound supramolecular hydrogel.
Through the above technical solutions, the advantageous effect of technical solution of the present invention is:The hydrogelator that the present invention uses is Chitosan is obtained by non-covalent bond self assembly, and aquagel is in spongelike structure.
Cordycepin is first nucleosides antibiotics separated from fungi, molecular formula C10H13N5O3.Antibacterial exists It is played an important role in wound healing process, cordycepin has the function of broad-spectrum antiseptic, it can inhibit some bacteriums, fungi etc. The growth of pathogen.In addition, cordycepin also has antiviral, immunological regulation, removes free radical, antitumor, anti-inflammatory etc. very extensively The biological activity of spectrum.
Chitosan (Chitosan) is a kind of hydrophilic natural polymer.Chitosan has good broad spectrum antibiotic activity, It can inhibit the growth and breeding of some fungies, bacterium and virus.Meanwhile chitosan has the function of promoting blood coagulation, can be used as stopping blooding Agent.It can be additionally used in wound healing, be reduced bacterial wound growth, absorb Wound exudate, be not easy the effects that syneresis, be excellent Good wound care dressings ingredient.In addition, chitosan has the function of thickener, the mechanical strength of composite material can be enhanced. Chitosan can be responsible for one of functional biological materials of wound healing.Chitosan has prodigious excellent as medicament sustained-release matrix More property can play synergistic effect in conjunction with cordycepin antibacterial advantage in antibacterial anti-inflammatory field.
1) composite natural product supramolecular hydrogel prepared by the present invention, biocompatibility is good, degradable, acellular Toxicity.
2) composite natural product supramolecular hydrogel prepared by the present invention has suitable hardness, elastic and sticky, and ten Divide suitable dermal application, is self-healing gel.
3) environmentally protective without adding any reducing agent and dispersant in preparation process of the present invention.
4) chitosan that the present invention is added can act synergistically with cordycepin, enhance the antibiotic property of hydrogel, it is easier to It smears, is conducive to the absorption of skin, it is made to be more suitable for making wound dressing.
5) preparation method of the present invention is simple, of low cost, can be commercialized, and is suitable for large-scale production.
6) compound supramolecular hydrogel prepared by the present invention has good antibiotic property, can effectively facilitate wound healing, will There can be good application prospect in fields in terms of antiseptic and wound dressing etc..
Description of the drawings
Fig. 1 is scanning electron microscope (SEM) figure of aquagel;
Fig. 2 is scanning electron microscope (SEM) figure of compound supramolecular hydrogel in the embodiment of the present invention 1;
Fig. 3 be the embodiment of the present invention 1 in compound supramolecular hydrogel at digital photograph figure before hydrogel;
Fig. 4 be the embodiment of the present invention 1 in compound supramolecular hydrogel at digital photograph figure after hydrogel
Bacterial growth situation after 12h on bacterium solution inoculation solid medium in Fig. 5 embodiments 1 in 1-3 fluid nutrient mediums Digital photograph figure, No. 1-3 arranges from left to right;
Fig. 6, Fig. 7 are to contrast effect figure.Fig. 6 is the digital photograph figure of the similar SD rats wound of weight size.Fig. 7 is 15 The digital photograph figure of wound healing situation after it, left column is the digital photograph figure without any processing to wound in Fig. 7, in be classified as The digital photograph figure containing only aquagel is smeared, the right side, which is classified as, smears compound supramolecular hydrogel in the embodiment of the present invention 2 Digital photograph figure.
Specific implementation mode
Below in conjunction with the embodiment of the present invention, technical scheme in the embodiment of the invention is clearly and completely described, Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Based in the present invention Embodiment, the every other embodiment that those of ordinary skill in the art are obtained without creative efforts, all Belong to the scope of protection of the invention.
Embodiment 1
The cordycepin solid powder for weighing 50.0mg, is dissolved in 500 μ L dimethyl sulfoxide (DMSO)s, and 5~10min of ultrasonic disperse makes it It is completely dissolved, the cordycepin solution (being kept in dark place) of a concentration of 100mg/mL is made;The chitosan of 400mg is weighed, 10mL is added The glacial acetic acid that volume ratio is 1% promotes the dissolving of chitosan, the chitosan for being made into 40mg/mL molten under the action of magnetic agitation Liquid.
It takes the cordycepin solution of 100 μ L to be added to clean drying to be protected from light in the 2.0mL screw socket bottles of processing, rapidly joins 400 μ The PBS buffer solutions of L, shake up rapidly, add the chitosan solution of 500 μ L, rapid oscillation, and magnetic agitation keeps its mixing equal It is even.In conjunction with Fig. 3, Fig. 4, which is put into -20 DEG C of refrigerator freezings, then thaw at RT (pays attention to when summer temp is excessively high in sky Adjust lower thaw) it can be obtained compound supramolecular hydrogel.Compound supramolecular hydrogel is scanned, is obtained shown in Fig. 2 Compound supramolecular hydrogel scanning electron microscope (SEM) figure.It can be compared with Fig. 1, compound supermolecule water In spongelike structure smoother and with different pore size inside gel.
Antibacterial experiment step:10.0g tryptones, 5.0g yeast extracts and 10.0g sodium chloride are weighed in beaker, to Ultrapure water dissolution is added in beaker, is stirred with glass bar and promotes dissolving, adjusts pH of mixed to 7.4 with sodium hydroxide, then uses Ultra-pure water is settled in the conical flask of 1L and prepares fluid nutrient medium.
10.0g tryptones, 5.0g yeast extracts, 10.0g sodium chloride and 15.0g agar are weighed, is added into beaker Ultrapure water dissolution is stirred with glass bar and promotes dissolving, is adjusted pH of mixed to 7.4 with sodium hydroxide, is then used ultra-pure water constant volume To fluid nutrient medium is prepared in the conical flask of 1L by prepared culture medium, bottleneck is stoppered with cotton, is packed tightly with gauze, then uses tin Foil paper encases, and cotton thread is fastened.Through 110 DEG C of high pressure sterilizations 30 minutes after being sealed.By the centrifuge tube of 3 10mL number 1-3 respectively, Respectively represent blank group (without any processing);Aquagel group;Chitosan/cordyceps sinensis hydrogel group;It will be in 4 DEG C of refrigerators Escherichia coli (gramnegative bacterium) bacterium solution frozen is taken out, and in aseptic operating platform, draws 100 μ L bacterium solutions respectively, is added 3 Centrifuge tube.The fluid nutrient medium of 6mL is added in No. 1 centrifuge tube;1.0mL aquagels are added in No. 2 centrifuge tubes, add The fluid nutrient medium of 5mL;The compound supramolecular hydrogel in the example 1 of 1.0mL is added in No. 3 centrifuge tubes, adds 5mL's Fluid nutrient medium;It shakes up and is placed on 37 DEG C of Tempeerature-constant air concussion and cultivate case cultures 4 hours.3 Micro-Organism Culture Dish to sterilize are taken, Number 1-3 respectively shakes up solid medium heating and melting, before cooling does not solidify, pours into 3 culture dishes respectively, each falls 20mL.10 μ L bacterium solutions are taken from centrifuge tube, are seeded to solid medium, are turned after substrate solidification, are placed in 37 DEG C Take pictures, and obtains photo shown in Fig. 5 to form bacterium colony by observation, taking-up within 12 hours for the culture of Tempeerature-constant air concussion and cultivate case.
Embodiment 2
The 100 μ L of cordycepin solution in above-described embodiment 1 are taken, is added to clean drying and is protected from light the 2.0mL screw socket bottles of processing In, 400 μ L PBS buffer solutions identical with 1 preparation method of embodiment are rapidly joined, are shaken up rapidly, 500 μ L is added and implements The chitosan solution of the identical 40mg/mL of 1 preparation method of example is uniformly mixed under magnetic stirring apparatus.The screw socket bottle is put into -20 DEG C refrigerator freezing, at room temperature thaw can be obtained composite natural product supramolecular hydrogel.
Zoopery step:Select healthy male Sprague-Dawley rat (180~220g)
Manufacture rat full skin wound model is to study the composite natural product supramolecular hydrogel of the present invention to wound The effect that mouth is cured.Entire zoopery process is completed in the Xiangya Medical College, Zhongnan Univ new camupus animal department of the Chinese Academy of Sciences.First by rat It weighs, using pentobarbital (yellow Jackets 2%, 2ml/kg) intraperitoneal injection of anesthesia rat, is struck off with electric shaver-for women The rat back hair anaesthetized, skin are sterilized with iodine complex solution clean before surgery.It is symmetrical in a rat back with mold The circle of three a diameter of 1cm is drawn, then is assisted by tweezers, the circular wound of a diameter of 1cm is cut with surgical scissors, as shown in Figure 6. Three wounds of every rat correspond to three groups:I groups are blank group (to wound without any processing), II groups are chitosan water-setting Glue group (control group), III groups are compound supramolecular hydrogel group, every group of 5 rats.It is individually closed after processing into cage, The food and water for providing equivalent, photograph to record, and raising 15 days is observed continuously, and replace bedding and padding, water and food daily and to mouse Wound healing situation is photographed to record.It is observed after 15 days, obtains photo described in Fig. 7.Chitosan can be cooperateed with cordycepin to be made With, can be applied in antiseptic and wound dressing, can achieve the purpose that enhance bactericidal property with promote wound healing.
The foregoing description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, as defined herein General Principle can be realized in other embodiments without departing from the spirit or scope of the present invention.Therefore, of the invention It is not intended to be limited to the embodiments shown herein, and is to fit to and the principles and novel features disclosed herein phase one The widest range caused.

Claims (9)

1. a kind of compound supramolecular hydrogel, which is characterized in that buffered including cordycepin solution, chitosan solution and PBS molten Liquid.
2. compound supramolecular hydrogel according to claim 1, which is characterized in that the cordycepin solution it is a concentration of 100mg/mL。
3. compound supramolecular hydrogel according to claim 2, which is characterized in that the solvent of the chitosan solution is 1%HAc, a concentration of 20~40mg/L of the chitosan solution.
4. compound supramolecular hydrogel according to claim 1, which is characterized in that the solvent of the PBS buffer solutions PH for ultra-pure water, the PBS buffer solutions is 8.3~8.5, each phosphate concn used is 0.1mol/L.
5. according to any compound supramolecular hydrogels of claim 1-4, which is characterized in that the compound supermolecule Hydrogel is applied in antiseptic or/and wound dressing.
6. a kind of preparation method of any compound supramolecular hydrogels of claim 1-4, which is characterized in that including with Lower step:
Step 1, the preparation of cordycepin solution;With dmso solution cordycepin solid powder, ultrasonic disperse obtains cordycepin Solution;
Step 2, the preparation of chitosan solution;Chitosan is dissolved with 1%HAc, magnetic agitation matches shelling to accelerate chitosan to dissolve Glycan solution;
Step 3, the preparation of PBS buffer solutions;Use Na2HPO4And NaH2PO4Solution allocation at different Ph PBS buffer solutions;
Step 4, after mixing by the cordycepin solution, chitosan solution and PBS buffer solutions, it is cold to be put into -20 DEG C of refrigerators It places after freezing to fully charge and thaws at room temperature, form the compound supramolecular hydrogel.
7. the preparation method of compound supramolecular hydrogel according to claim 6, which is characterized in that described in step 1 Dmso solution cordycepin solid powder is 5~10min by the time of ultrasonic disperse, and gained cordycepin solution concentration is 100mg/mL carries out being protected from light processing during preparing the cordycepin solution.
8. the preparation method of compound supramolecular hydrogel according to claim 6, which is characterized in that described in step 2 A concentration of 20~40mg/ml of chitosan solution;In step 3, the Ph of the PBS buffer solutions is 8.3~8.5, and the PBS is slow It rushes in solution, Na2HPO4 and NaH2PO4 concentration is 0.1mol/L.
9. the preparation method of compound supramolecular hydrogel according to claim 7, which is characterized in that step 4, take 80 μ L The cordycepin solution of~100 μ L, which is added to the 2.0mL of clean drying, to be protected from light in the screw socket bottle of processing, rapidly join 400~ The PBS buffer solutions of 420 μ L, shake up rapidly, add the chitosan solution of 500 μ L, and the mixing for being made into 1.0mL is molten The process for preparation of liquid, the mixed solution carries out under magnetic stirring;It waits for the mixed solution after mixing, screw socket bottle is put Enter to place after -20 DEG C of refrigerator freezings to fully charge and thaw at room temperature, forms the compound supramolecular hydrogel.
CN201810421517.6A 2018-05-04 2018-05-04 Composite supermolecule hydrogel and preparation method thereof Expired - Fee Related CN108452370B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810421517.6A CN108452370B (en) 2018-05-04 2018-05-04 Composite supermolecule hydrogel and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810421517.6A CN108452370B (en) 2018-05-04 2018-05-04 Composite supermolecule hydrogel and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108452370A true CN108452370A (en) 2018-08-28
CN108452370B CN108452370B (en) 2020-09-11

Family

ID=63214816

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810421517.6A Expired - Fee Related CN108452370B (en) 2018-05-04 2018-05-04 Composite supermolecule hydrogel and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108452370B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109280184A (en) * 2018-09-28 2019-01-29 湖州斯蔓生物材料有限公司 Preparation method, CMCs system prepared therefrom hydrogel and its application of CMCs system hydrogel
CN112641995A (en) * 2020-12-21 2021-04-13 上海交通大学 Chiral hydrogel dressing with antibacterial and repair promoting functions and preparation method and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047186A1 (en) * 1998-03-18 1999-09-23 University Of Pittsburgh Chitosan-based composite materials containing glycosaminoglycan for cartilage repair
CN104017050A (en) * 2014-06-19 2014-09-03 周礼红 Cordyceps militaris antibacterial peptide and preparation method thereof
CN104474980A (en) * 2014-11-07 2015-04-01 中南大学 Supermolecule hybridized hydrogel, graphene aerogel, preparation methods and application of two
CN105646902A (en) * 2016-04-01 2016-06-08 江苏大学 Preparation method of iron-chitosan metal supermolecular gel
CN106146862A (en) * 2015-03-31 2016-11-23 中南大学 A kind of supermolecule heterozygosis hydrogel of antibiotic property and its preparation method and application
CN106667986A (en) * 2017-01-24 2017-05-17 中南大学湘雅医院 Rhein/chitosan hydrogel and preparation method and application thereof
CN106692037A (en) * 2017-01-24 2017-05-24 中南大学湘雅医院 Rhein supramolecular hydrogel and preparation method and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047186A1 (en) * 1998-03-18 1999-09-23 University Of Pittsburgh Chitosan-based composite materials containing glycosaminoglycan for cartilage repair
CN104017050A (en) * 2014-06-19 2014-09-03 周礼红 Cordyceps militaris antibacterial peptide and preparation method thereof
CN104474980A (en) * 2014-11-07 2015-04-01 中南大学 Supermolecule hybridized hydrogel, graphene aerogel, preparation methods and application of two
CN106146862A (en) * 2015-03-31 2016-11-23 中南大学 A kind of supermolecule heterozygosis hydrogel of antibiotic property and its preparation method and application
CN105646902A (en) * 2016-04-01 2016-06-08 江苏大学 Preparation method of iron-chitosan metal supermolecular gel
CN106667986A (en) * 2017-01-24 2017-05-17 中南大学湘雅医院 Rhein/chitosan hydrogel and preparation method and application thereof
CN106692037A (en) * 2017-01-24 2017-05-24 中南大学湘雅医院 Rhein supramolecular hydrogel and preparation method and application thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109280184A (en) * 2018-09-28 2019-01-29 湖州斯蔓生物材料有限公司 Preparation method, CMCs system prepared therefrom hydrogel and its application of CMCs system hydrogel
CN112641995A (en) * 2020-12-21 2021-04-13 上海交通大学 Chiral hydrogel dressing with antibacterial and repair promoting functions and preparation method and application thereof
CN112641995B (en) * 2020-12-21 2021-11-23 上海交通大学 Chiral hydrogel dressing with antibacterial and repair promoting functions and preparation method and application thereof

Also Published As

Publication number Publication date
CN108452370B (en) 2020-09-11

Similar Documents

Publication Publication Date Title
Xue et al. Bioinspired multifunctional biomaterials with hierarchical microstructure for wound dressing
WO2019091150A1 (en) Alginate wound repair dressing and preparation method thereof
CN110354295B (en) Photo-thermal conversion material and preparation method thereof
CN100528231C (en) Anti-inflammatory and antimicrobial uses for bioactive glass compositions
CN107185031B (en) A kind of biologically active medical dressing and preparation method thereof
CN101502667B (en) Medical chitosan transparent hydrogel wound dressing as well as preparation and application thereof
CN106075556A (en) Containing the medical recombination chitosan gel promoting wound healing medicine
CN102335451B (en) Medical colloid dressing with functions for inhibiting bacteria and promoting heal and application thereof
CN105778126A (en) Genipin cross-linked biogel as well as preparation method and application thereof
CN107802878A (en) A kind of modified gelatin/potassium-sodium niobate compound electroactive antibacterial biological dressing and its preparation and application
CN103933553B (en) A kind of nano-particle containing antibacterial peptide and cell growth factor being used for the treatment of acne
CN102319448A (en) Antibacterial aquagel material for preparing medical wound dressing and preparation method thereof
CN102302797B (en) Medical colloid dressing and application thereof
CN107617121B (en) Biological induction active dressing for skin wound surface and preparation method and application thereof
CN106215239B (en) A kind of preparation method of crosslinked antimicrobial type acellular matrix material
CN103755965A (en) Polylysine hydrogel and preparation method and application thereof
CN109731130A (en) A kind of method that low-temperature biological 3D printing technique prepares hydrogel Wound dressing
WO2024012190A1 (en) Double-layer bionic drug-loaded hydrogel, and preparation and use thereof
US20210015966A1 (en) Antibacterial Cellulose Hydrogels and Preparation Method therefor
CN108452370A (en) A kind of compound supramolecular hydrogel and preparation method thereof
CN109966540B (en) Preparation method and application of nano chitin composite calcium alginate medical dressing
RU2699362C2 (en) Composition based on cerium dioxide nanoparticles and brown algae polysaccharides for treating wounds
CN104740141B (en) A kind of antimicrobial spray and preparation method thereof
Rajkumar et al. Chitosan-Based Biomaterial in Wound Healing: A Review
CN112245651A (en) Temperature-sensitive composite antibacterial hydrogel with good photothermal effect and application method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200911